SEARCH:   Advanced

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Izutsu, K. Articles by Hirai, H. Search for Related Content PubMed PubMed Citation Articles by Izutsu, K. Articles by Hirai, H. Related Collections Neoplasia Gene Expression Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, 1 May 2001, Vol. 97, No. 9, pp. 2815-2822 NEOPLASIA The corepressor CtBP interacts with Evi-1 to repress transforming growth factor  signaling Koji Izutsu, Mineo Kurokawa, Yoichi Imai, Kazuhiro Maki, Kinuko Mitani, and Hisamaru Hirai From the Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo, Japan. Evi-1 is a zinc finger nuclear protein whose inappropriate expression leads to leukemic transformation of hematopoietic cells in mice and humans. This was previously shown to block the antiproliferative effect of transforming growth factor  (TGF-). Evi-1 represses TGF- signaling by direct interaction with Smad3 through its first zinc finger motif. Here, it is demonstrated that Evi-1 represses Smad-induced transcription by recruiting C-terminal binding protein (CtBP) as a corepressor. Evi-1 associates with CtBP1 through one of the consensus binding motifs, and this association is required for efficient inhibition of TGF- signaling. A specific inhibitor for histone deacetylase (HDAc) alleviates Evi-1-mediated repression of TGF- signaling, suggesting that HDAc is involved in the transcriptional repression by Evi-1. This identifies a novel function of Evi-1 as a member of corepressor complexes and suggests that aberrant recruitment of corepressors is one of the mechanisms for Evi-1-induced leukemogenesis. © 2001 by The American Society of Hematology.   CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: G. Chinnadurai The Transcriptional Corepressor CtBP: A Foe of Multiple Tumor Suppressors Cancer Res., February 1, 2009; 69(3): 731 - 734. [Abstract] [Full Text] [PDF] R. Alpatov, Y. Shi, G. C. Munguba, B. Moghimi, J.-H. Joo, J. Bungert, and S. P. Sugrue Corepressor CtBP and Nuclear Speckle Protein Pnn/DRS Differentially Modulate Transcription and Splicing of the E-Cadherin Gene Mol. Cell. Biol., March 1, 2008; 28(5): 1584 - 1595. [Abstract] [Full Text] [PDF] W. Blum, R. B. Klisovic, B. Hackanson, Z. Liu, S. Liu, H. Devine, T. Vukosavljevic, L. Huynh, G. Lozanski, C. Kefauver, et al. Phase I Study of Decitabine Alone or in Combination With Valproic Acid in Acute Myeloid Leukemia J. Clin. Oncol., September 1, 2007; 25(25): 3884 - 3891. [Abstract] [Full Text] [PDF] S.-Y. Wang, M. Iordanov, and Q. Zhang c-Jun NH2-terminal Kinase Promotes Apoptosis by Down-regulating the Transcriptional Co-repressor CtBP J. Biol. Chem., November 17, 2006; 281(46): 34810 - 34815. [Abstract] [Full Text] [PDF] K. G. R. Quinlan, A. Verger, A. Kwok, S. H. Y. Lee, J. Perdomo, M. Nardini, M. Bolognesi, and M. Crossley Role of the C-Terminal Binding Protein PXDLS Motif Binding Cleft in Protein Interactions and Transcriptional Repression Mol. Cell. Biol., November 1, 2006; 26(21): 8202 - 8213. [Abstract] [Full Text] [PDF] J. S. Sunde, H. Donninger, K. Wu, M. E. Johnson, R. G. Pestell, G. S. Rose, S. C. Mok, J. Brady, T. Bonome, and M. J. Birrer Expression Profiling Identifies Altered Expression of Genes That Contribute to the Inhibition of Transforming Growth Factor-{beta} Signaling in Ovarian Cancer. Cancer Res., September 1, 2006; 66(17): 8404 - 8412. [Abstract] [Full Text] [PDF] M. Dong and G. C. Blobe Role of transforming growth factor-beta in hematologic malignancies Blood, June 15, 2006; 107(12): 4589 - 4596. [Abstract] [Full Text] [PDF] A. C. Brown, S. J. Baigent, L. P. Smith, J. P. Chattoo, L. J. Petherbridge, P. Hawes, M. J. Allday, and V. Nair Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus PNAS, February 7, 2006; 103(6): 1687 - 1692. [Abstract] [Full Text] [PDF] J. Massague, J. Seoane, and D. Wotton Smad transcription factors Genes & Dev., December 1, 2005; 19(23): 2783 - 2810. [Abstract] [Full Text] [PDF] B. Yatsula, S. Lin, A. J. Read, A. Poholek, K. Yates, D. Yue, P. Hui, and A. S. Perkins Identification of Binding Sites of EVI1 in Mammalian Cells J. Biol. Chem., September 2, 2005; 280(35): 30712 - 30722. [Abstract] [Full Text] [PDF] J. E. Burdette, J. S. Jeruss, S. J. Kurley, E. J. Lee, and T. K. Woodruff Activin A Mediates Growth Inhibition and Cell Cycle Arrest through Smads in Human Breast Cancer Cells Cancer Res., September 1, 2005; 65(17): 7968 - 7975. [Abstract] [Full Text] [PDF] T. Alliston, T. C. Ko, Y. Cao, Y.-Y. Liang, X.-H. Feng, C. Chang, and R. Derynck Repression of Bone Morphogenetic Protein and Activin-inducible Transcription by Evi-1 J. Biol. Chem., June 24, 2005; 280(25): 24227 - 24237. [Abstract] [Full Text] [PDF] A. K. Kamaraju and A. B. Roberts Role of Rho/ROCK and p38 MAP Kinase Pathways in Transforming Growth Factor-{beta}-mediated Smad-dependent Growth Inhibition of Human Breast Carcinoma Cells in Vivo J. Biol. Chem., January 14, 2005; 280(2): 1024 - 1036. [Abstract] [Full Text] [PDF] R. Alpatov, G. C. Munguba, P. Caton, J. H. Joo, Y. Shi, Y. Shi, M. E. Hunt, and S. P. Sugrue Nuclear Speckle-Associated Protein Pnn/DRS Binds to the Transcriptional Corepressor CtBP and Relieves CtBP- Mediated Repression of the E-Cadherin Gene Mol. Cell. Biol., December 1, 2004; 24(23): 10223 - 10235. [Abstract] [Full Text] [PDF] A. Castet, A. Boulahtouf, G. Versini, S. Bonnet, P. Augereau, F. Vignon, S. Khochbin, S. Jalaguier, and V. Cavailles Multiple domains of the Receptor-Interacting Protein 140 contribute to transcription inhibition Nucleic Acids Res., April 1, 2004; 32(6): 1957 - 1966. [Abstract] [Full Text] [PDF] A. Chittka, J. C. Arevalo, M. Rodriguez-Guzman, P. Perez, M. V. Chao, and M. Sendtner The p75NTR-interacting protein SC1 inhibits cell cycle progression by transcriptional repression of cyclin E J. Cell Biol., March 29, 2004; 164(7): 985 - 996. [Abstract] [Full Text] [PDF] X. Lin, Y.-Y. Liang, B. Sun, M. Liang, Y. Shi, F. C. Brunicardi, Y. Shi, and X.-H. Feng Smad6 Recruits Transcription Corepressor CtBP To Repress Bone Morphogenetic Protein-Induced Transcription Mol. Cell. Biol., December 15, 2003; 23(24): 9081 - 9093. [Abstract] [Full Text] [PDF] F. Tian, S. DaCosta Byfield, W. T. Parks, S. Yoo, A. Felici, B. Tang, E. Piek, L. M. Wakefield, and A. B. Roberts Reduction in Smad2/3 Signaling Enhances Tumorigenesis but Suppresses Metastasis of Breast Cancer Cell Lines Cancer Res., December 1, 2003; 63(23): 8284 - 8292. [Abstract] [Full Text] [PDF] I. Nishikata, H. Sasaki, M. Iga, Y. Tateno, S. Imayoshi, N. Asou, T. Nakamura, and K. Morishita A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation Blood, November 1, 2003; 102(9): 3323 - 3332. [Abstract] [Full Text] [PDF] L. A. van Grunsven, C. Michiels, T. Van de Putte, L. Nelles, G. Wuytens, K. Verschueren, and D. Huylebroeck Interaction between Smad-interacting Protein-1 and the Corepressor C-terminal Binding Protein Is Dispensable for Transcriptional Repression of E-cadherin J. Biol. Chem., July 3, 2003; 278(28): 26135 - 26145. [Abstract] [Full Text] [PDF] H. Hirai Molecular Mechanisms of Myelodysplastic Syndrome Jpn. J. Clin. Oncol., April 1, 2003; 33(4): 153 - 160. [Abstract] [Full Text] [PDF] S. Cote, A. Rosenauer, A. Bianchini, K. Seiter, J. Vandewiele, C. Nervi, and W. H. Miller Jr Response to histone deacetylase inhibition of novel PML/RARalpha mutants detected in retinoic acid-resistant APL cells Blood, September 18, 2002; 100(7): 2586 - 2596. [Abstract] [Full Text] [PDF] J. D. Hildebrand and P. Soriano Overlapping and Unique Roles for C-Terminal Binding Protein 1 (CtBP1) and CtBP2 during Mouse Development. Mol. Cell. Biol., August 1, 2002; 22(15): 5296 - 5307. [Abstract] [Full Text] [PDF] S. Deltour, S. Pinte, C. Guerardel, B. Wasylyk, and D. Leprince The Human Candidate Tumor Suppressor Gene HIC1 Recruits CtBP through a Degenerate GLDLSKK Motif Mol. Cell. Biol., July 1, 2002; 22(13): 4890 - 4901. [Abstract] [Full Text] [PDF] S. G. Katz, A. B. Cantor, and S. H. Orkin Interaction between FOG-1 and the Corepressor C-Terminal Binding Protein Is Dispensable for Normal Erythropoiesis In Vivo Mol. Cell. Biol., May 1, 2002; 22(9): 3121 - 3128. [Abstract] [Full Text] [PDF] S. Dennler, M.-J. Goumans, and P. ten Dijke Transforming growth factor {beta} signal transduction J. Leukoc. Biol., May 1, 2002; 71(5): 731 - 740. [Abstract] [Full Text] [PDF] D. Liu, B. L. Black, and R. Derynck TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3 Genes & Dev., November 15, 2001; 15(22): 2950 - 2966. [Abstract] [Full Text] [PDF] S. Chakraborty, V. Senyuk, S. Sitailo, Y. Chi, and G. Nucifora Interaction of EVI1 with cAMP-responsive Element-binding Protein-binding Protein (CBP) and p300/CBP-associated Factor (P/CAF) Results in Reversible Acetylation of EVI1 and in Co-localization in Nuclear Speckles J. Biol. Chem., November 21, 2001; 276(48): 44936 - 44943. [Abstract] [Full Text] [PDF]

	Copyright © 2001 by American Society of Hematology         Online ISSN: 1528-0020